Vaccines have been instrumental in improving human health for centuries, but there are still significant challenges to address, such as improving existing vaccines, responding quickly to emerging infectious disease outbreaks, and simplifying vaccine research and development processes. The recent success of mRNA vaccines against SARS-CoV-2 has demonstrated their potential to tackle these challenges. By delivering mRNA encoding the antigen into cells, mRNA vaccines can induce potent and broad-based immunity, similar to live virus infection. Additionally, synthetic production methods used in mRNA vaccines simplify and accelerate vaccine manufacturing and characterization, making it easier to get life-saving products to those in need. In this article, Jeffrey Ulmer explains the advantages and potential of mRNA vaccines in the fight against infectious diseases.

The full article from BIOINSIGHTS can be found here:

https://insights.bio/vaccine-insights/journal/article/2786/Whats-next-for-mRNA-vaccines

What’s next for mRNA vaccines?, Jeffrey Ulmer, Vaccine Insights 2023; 2(3), 93–96, DOI: 10.18609/vac.2023.017, PUBLISHED: 9 APRIL 2023